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Pyrazoles and their derivatives are well recognized as an important class of heterocyclic compounds that have been found with extensive use in the pharmaceutical, material, and agrochemical industries. 1 Compounds containing pyrazole moiety have exhibited diverse biological activities. For example, 4-substituted 1,5-diaryl-1H-pyrazole-3-carboxylate derivatives can act as cannabinoid-1 (CB1) receptor antagonists, [2] [3] [4] [5] [6] [7] Iκβ kinase β (IKKβ or IKK-2) inhibitors, 8 and antiinflammatory agents. 9 Pyrazole derivatives have been shown to have good binding affinity towards estrogen receptor. [10] [11] [12] Some of the pyrazole derivatives have been reported to possess antidepressant, anticonvulsant, 13 anti-inflammatory, and arthritics 14 activities. Pyrazole scaffold constitutes the basic framework of several drug molecules such as celecoxib (a non-steroidal anti-inflammatory drug) 14 and rimonabant (an anorectic antiobesity drug) ( Figure 1 ). Because of their diverse bioactivities, pyrazoles have received considerable attention of chemists. Thus, a number of synthetic strategies have been developed for their synthesis. 15, 16 The most common approach for synthesis of substituted pyrazoles is the condensation of α,β-unsaturated carbonyl compounds with hydrazines. 2 23 , and TBBDA
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. However, many of these oxidative methods suffer from relatively high oxidant loading, use of strong oxidants and chlorinated organic solvents, harsh conditions, poor yields, and longer reaction time.
Thus, the development of environmentally benign processes with the use of alternative solvents such as ionic liquids in place of organic solvent and a catalytic amount of ecofriendly catalysts that avoid harsh oxidizing reagents are desirable.
As part of our ongoing work on the development of novel reaction methodologies using metal triflates, [25] [26] [27] and evaluation of small molecules as anticancer agents, 27 [11] [12] . There was not much increase in yield of 4a on changing the amount of Cu(OTf) 2 from 20 mol% to 30 mol%. However, reducing the amount of Cu(OTf) 2 to 10 mol% decreased the yield of 4a to 64% along with the formation of 3a in 15% ( Table 1 , entries 1-3). These data indicate that Cu(OTf) 2 was involved in aerobic oxidation of 3a to 4a. It is necessary to mention that 4a was not formed in the absence of Cu(OTf) 2 in [bmim [PF 6 ] ionic liquids, and only 3a was isolated along with starting material. The structure of compound 4a was confirmed by 1 H NMR, 13 C NMR, and high-resolution mass spectroscopy. In the 1 H NMR spectra, a singlet was observed at δ 6.81 for the proton at C-4 position of pyrazole ring along with other protons on aryl substituents. In 13 C NMR, a peak appeared at δ 104.97 for the C-4 carbon of pyrazole ring. HRMS of 4a showed a peak at m/z for molecular ion. Thus, NMR and mass analysis confirmed that the product was pyrazole and not pyrazoline.
To explore the synthetic scope and versatility of the protocol, a series of aryl hydrazines 2 were reacted with different α,β-carbonyl compounds (1) under the optimal reaction conditions. The results are summarized in Table 2 . Various groups, such as F, Cl, NO 2, OCH 3 , CH 3 and -C(CH 3 ) 3 on aryl hydrazines and chalcones were well tolerated in these conditions affording the corresponding 1,3,4-substituted pyrazoles (4a-o) in good to high yields (71-82%). 6 ] at different time interval it was found that in first 30 minutes pyrazoline (3a) was the major product, which got oxidized to pyrazole in the reaction as time progresses. We thus decided to synthesize the pyrazolines using this protocol in order to evaluate them in our biological assay. The reaction of 1 and hydrazines 2 afforded 1,3-pyrazolines 3a-o via a one-pot addition-cyclocondensation process in good to high yields (60-84%). Several α,β-unsaturated carbonyl compounds with both electron-rich and electrondeficient arenes were successfully applied to this reaction. The results of pyrazoline synthesis are summarized in Table 3 . The chemical structures of all synthesized compounds were elucidated by 1 H NMR, 13 C NMR, and high-resolution mass spectroscopy (Supporting information). Based on the intermediate formed (3a) and structure of the product (4a) as analyzed by NMR, the reaction is proposed to proceed through the sequential steps as shown in Scheme 2. The first step is believed to be 1,4-addition of hydrazine to chalcone mediated by copper (II) triflate. The 3-hydrazino ketone undergoes nucleophilic addition followed by elimination to give 1,3,5-triarylpyrazolines derivative. 1,3,5-Triarylpyrazolines derivatives undergo oxidative aromatization in the presence of copper (II) triflate to yield corresponding 1,3,5-triarylpyrazole derivatives. It appeared that ionic liquid helps in stabilization of charged intermediate generated by coordination of Cu(OTf) 2 to carbonyl of chalcone and thereby increases electrophilicity of chalcone.
Further, we investigated the possibility of recycling of the catalyst. After performing the first cycle, the product was extracted with ethyl acetate/hexane mixture, and Cu(OTf) 2 in ionic liquid was properly dried under pressure. Furthermore, the fresh chalcone and 4-tert-butyl phenylhydrazine hydrochloride were charged under same conditions. The above procedure was repeated four times to give 4a in high yields (82, 80, 78, and 79%) without much loss of catalytic activity. To evaluate the anticancer activity of synthesized compounds, all derivatives (4a-o and 3a-n) were evaluated for their inhibitory activity on the proliferation of human ovarian adenocarcinoma (SK-OV-3), human colon adenocarcinoma (HT-29), and human cervical adenocarcinoma (HeLa) cells. Doxorubicin (Dox) and DMSO were used as positive and negative controls, respectively. The antiproliferative activity results of compounds 4a-o and 3a-n at 50 µM after 72 h incubation are shown in Figures 2 and 3 , respectively. Figure 2 shows that among all 1,3,5-triarylpyrazoles derivatives, compounds 4c, 4e, 4f, 4g, 4h, 4i, and 4k inhibit the proliferation of HeLa cells by 50%, 55%, 45%, 39%, 54%, 42%, and 50%, respectively. However, they did not exhibit significant inhibitory potency in HT-29 and SK-OV-3 cells. 6 ] ionic liquid mediated by Cu(OTf) 2 . The reaction protocol exhibited tolerance with different functional groups, generating pyrazoles in good to high yields (71-82%) without any requirement for additional reagent for the oxidation of in situ generated pyrazolines. The catalyst can be reused up to five cycles without much loss in catalytic activity. The pyrazoles (4a-o) and pyrazolines (3a-n) were evaluated for antiproliferative activity. Compound 3b inhibited cell proliferation of HeLa cells by 80% at a concentration of 50 µM. All other synthesized derivatives exhibited a modest inhibition against the proliferation of SK-OV-3, HT-29 and HeLa cells. Further structure-activity relationship studies are required for optimizing antiproliferative activities of these classes of compounds.
